Infect Chemother.  2014 Mar;46(1):59-61. 10.3947/ic.2014.46.1.59.

Clinical Characteristics of Vivax Malaria Outside Northern Gyeonggi Province Korea

• Lee JH
• Lee YJ
• Hwang JH
• Lee CS

• KMID: 2170463
• DOI: http://doi.org/10.3947/ic.2014.46.1.59

Abstract

No abstract available.

MeSH Terms

Gyeonggi-do*
Korea*
Malaria, Vivax*

Figure

• 

  Figure 1 Distribution of study patient residences. Triangles indicate residences of patients in this study, and circles indicate residences of patients from the study by Kwak et al [1].

Reference

1. Kwak YG, Lee HK, Kim M, Um TH, Cho CR. Clinical characteristics of vivax malaria and analysis of recurred patients. Infect Chemother. 2013; 45:69–75.

2. Yeom JS, Park JW. Status of vivax malaria after re-emergence in South Korea. Infect Chemother. 2008; 40:191–198.

3. Park JW, Klein TA, Lee HC, Pacha LA, Ryu SH, Yeom JS, Moon SH, Kim TS, Chai JY, Oh MD, Choe KW. Vivax malaria: a continuing health threat to the Republic of Korea. Am J Trop Med Hyg. 2003; 69:159–167.

4. Kim SJ, Kim SH, Jo SN, Gwack J, Youn SK, Jang JY. The long and short incubation periods of Plasmodium vivax malaria in Korea: The characteristics and relating factors. Infect Chemother. 2013; 45:184–193.

5. Kho WG. Reemergence of malaria in Korea. J Korean Med Assoc. 2007; 50:959–966.

6. Kim TS, Kim JS, Na BK, Lee WJ, Kim HC, Youn SK, Gwack J, Kim HS, Cho P, Ahn SK, Cha SH, Park YK, Lee SK, Kang YJ, Sohn Y, Hong Y, Lee HW. Decreasing incidence of Plasmodium vivax in the Republic of Korea during 2010-2012. Malar J. 2013; 12:309.